歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁 > 小分子抑制劑 > TyrosineKinase/Adaptors > RXDX-106 (CEP-40783)

瀏覽歷史

S81334

RXDX-106 (CEP-40783)

源葉(MedMol) ≥98%
  • 英文名:
  • RXDX-106 (CEP-40783)
  • 別名:
  • CAS號(hào):
  • 1437321-24-8
  • 分子式:
  • C31H26F2N4O6
  • 分子量:
  • 588.558
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S81334-1mg ≥98% ¥360.00元 10 - - - EA 加入購物車
源葉(MedMol) S81334-5mg ≥98% ¥1090.00元 10 - - - EA 加入購物車
源葉(MedMol) S81334-10mg ≥98% ¥1750.00元 8 - - - EA 加入購物車
源葉(MedMol) S81334-25mg ≥98% ¥3934.00元 3 - - - EA 加入購物車
源葉(MedMol) S81334-50mg ≥98% ¥7086.00元 1 - - - EA 加入購物車
源葉(MedMol) S81334-100mg ≥98% ¥12450.00元 1 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說明書。
  • 產(chǎn)品描述: CEP-40783 is a potent, selective and orally available inhibitor of AXL and c-Met with IC50 values of 7 nM and 12 nM, respectively.
  • 靶點(diǎn): IC50: 7 nM (AXL) and 12 nM (c-Met);c-Met/HGFR;?TAMReceptor
  • 體內(nèi)研究:
    CEP-40783 shows dose- and time-dependent inhibition of AXL phosphorylation using NCI-H1299 NSCL xenografts with 80% target inhibition at 0.3 mg/kg 6 h post dose and complete target inhibition to >90% inhibition at 1 mg/kg between 6-24 h, while a 10 mg/kg po dose resulted in complete AXL inhibition up to 48 h post dosing. In 3/5 (60%) of the tumor models, CEP-40783 shows in vivo efficacy, including tumor regressions, significantly superior to that achieved with an optimal regimen of paclitaxel. In 4/4 (100%) of the erlotinib-insensitive tumor models, CEP-40783 demonstrates significant efficacy (66 to 118% TGI) compared to the control group at the 30 mg/kg dose. Additionally, CEP-40783 in combination with erlotinib demonstrate superior anti-tumor efficacy compared to CEP-40783 and erlotinib single agents in the one erlotinib-sensitive model evaluated. CEP-40783 as a single agent and in combination with erlotinib are well tolerated
  • 參考文獻(xiàn):
    1. Sheila M, et al. CEP-40783: A potent and selective AXL/c-Met inhibitor for use in breast, non-small cell lung (NSCLC), and pancreatic cancers. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therape 2. Jay F, et al. Antitumor activity of the dual AXL/c-Met inhibitor CEP-40783 in Champions primary TumorGraft models of human non-small cell lung cancer (NSCLC). [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets a
  • 溶解性: Soluble  in  DMSO
  • 保存條件: RT
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.699 ml 8.495 ml 16.991 ml
    5 mM 0.34 ml 1.699 ml 3.398 ml
    10 mM 0.17 ml 0.85 ml 1.699 ml
    50 mM 0.034 ml 0.17 ml 0.34 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。